Japanese Journal of Cardiovascular Surgery Vol47,No2

Long-Term Function of Hydrofit as Hemostatic Agent
Hiromichi Sonoda* Tomoki Ushijima* Yasuhisa Oishi*
Kazuhiro Hinokiyama* Hideki Tatewaki* Yoshihisa Tanoue*
Akira Shiose*

(Department of Cardiovascular Surgery, Kyushu University Hospital, Fukuoka, Japan)

Bleeding control during aortic surgery is one of the most important issue. The well-known fibrinogen-based hemostat contains the blood product, which means the potential risk of the blood-related infection. Recently, the newly-designed hemostat “Hydrofit”, which is assembled with urethane-based polymer without blood product(Matsudyte:Sanyo-chemical industry, Kyoto, Japan). Hydrofit is applicated for the hemostasis of thoracic aortic surgery. In sealing of the Hydrofit gel to the anastomosis site of aorta, water-contact initiation boosts the chemical change to the forming elastomer and adheres around anastomosis site rapidly. We experienced the extirpation of the Hydrofit which was used over 4 years ago. The patient is 42 year-old female who was operated aortic valve replacement and graft replacement of ascending aorta using a Hydrofit as a hemostat at 4 year 8 months ago due to the aortitis syndrome. Re-sternotomy and re-AVR was performed because of the prosthetic valve dehiscence due to the active aortitis syndrome. Hydrofit left around suture line without infection, and functioned very well as the elastic sealant for the long-term period.

 

Jpn. J. Cardiovasc. Surg. 47:62-65(2018)

Keywords:Hydrofit;Matsudyte;long-term removal;ascending aortic replacement


Copyright ©2018 By Japanese Society for Cardiovascular Surgery All rights reserved.

PAGE TOP ▲